CIO at Guardant Health (NASDAQ: GH) sells 40K shares after option exercises
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Guardant Health Chief Information Officer Kumud Kalia exercised stock options and sold shares on March 4, 2026. He exercised multiple stock option awards, converting them into common stock at exercise prices including $47.20, $74.00, $32.86, $28.37, and $28.61 per share.
On the same date, he sold a total of 40,000 shares of Guardant Health common stock in open-market transactions at weighted average prices of about $95.12 and $95.73 per share, across ranges disclosed in the footnotes. After these trades, he directly held 37,643 shares of common stock.
The option awards he exercised were originally granted between April 20, 2020 and November 8, 2024 and vest over three- or four-year schedules, with initial portions vesting on specified dates and remaining shares vesting in equal monthly installments thereafter.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Seller: 40,000 shares ($3,812,661)
Net Sell
14 txns
Insider
Kalia Kumud
Role
Chief Information Officer
Sold
40,000 shs ($3.81M)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 2,119 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 15,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 1,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 5,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
| Exercise | Stock Option (Right to Buy) | 10,000 | $0.00 | -- |
| Exercise | Common Stock | 2,119 | $47.20 | $100K |
| Exercise | Common Stock | 15,000 | $47.20 | $708K |
| Exercise | Common Stock | 1,000 | $74.00 | $74K |
| Exercise | Common Stock | 5,000 | $32.86 | $164K |
| Exercise | Common Stock | 10,000 | $28.37 | $284K |
| Exercise | Common Stock | 10,000 | $28.61 | $286K |
| Sale | Common Stock | 26,980 | $95.119 | $2.57M |
| Sale | Common Stock | 13,020 | $95.7258 | $1.25M |
Holdings After Transaction:
Stock Option (Right to Buy) — 49,305 shares (Direct);
Common Stock — 36,643 shares (Direct)
Footnotes (1)
- Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $94.460 to $95.455. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. Represents the weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $95.46 to $96.14. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range. This represents a stock option award granted on November 7, 2022 that vests over a four-year period. 25% of the shares subject to such award vested on November 7, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. This represents a stock option award granted on April 20, 2020 that vests over a four-year period. 25% of the shares subject to such award vested on January 7, 2021 and the remaining 75% of the shares vested in equal monthly installments over the three-year period thereafter. This represents a stock option award granted on June 9, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on June 9, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. This represents a stock option award granted on December 13, 2023 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2024 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter. This represents a stock option award granted on November 8, 2024 that vests over a three-year period. 33% of the shares subject to such award vested on October 1, 2025 and the remaining 67% of the shares vests in equal monthly installments over the remaining two-year period thereafter.
FAQ
What did Guardant Health (GH) insider Kumud Kalia report in this Form 4?
Kumud Kalia reported exercising multiple stock options and selling common shares of Guardant Health on March 4, 2026. The filing details option exercises into common stock followed by open-market sales totaling 40,000 shares, with remaining direct ownership of 37,643 shares afterward.
At what prices were the Guardant Health (GH) insider sales executed?
The reported sales used weighted average prices of about $95.1190 and $95.7258 per share. Footnotes state the 26,980-share block traded between $94.460–$95.455, and the 13,020-share block between $95.46–$96.14, with full breakdowns available on request.
What stock options did the Guardant Health (GH) CIO exercise?
He exercised several stock option awards granted on April 20, 2020, November 7, 2022, June 9, 2023, December 13, 2023, and November 8, 2024. These options vest over three or four years, with initial tranches vesting on specified dates and the rest monthly thereafter.
Were the Guardant Health (GH) insider sales made in single or multiple trades?
The 40,000 Guardant Health shares were sold in multiple transactions within price ranges. One block traded between $94.460–$95.455 and the other between $95.46–$96.14. Weighted average prices are reported, with full per-trade details available upon request.